Home/Filings/8-K/0001104659-25-123099
8-K//Current report

MetaVia Inc. 8-K

Accession 0001104659-25-123099

$MTVACIK 0001638287operating

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 4:01 PM ET

Size

236.3 KB

Accession

0001104659-25-123099

Research Summary

AI-generated summary of this filing

Updated

MetaVia Inc. Regains Nasdaq Minimum Bid Price Compliance

What Happened
MetaVia Inc. (MTVA) announced in an 8-K (Item 8.01) that Nasdaq has notified the company it has regained compliance with the minimum bid price requirement. Nasdaq's Notice, received December 19, 2025, states the company's common stock closed at $1.00 per share or greater for 10 consecutive business days from December 5, 2025 through December 18, 2025, satisfying Nasdaq Listing Rule 5550(a)(2).

Key Details

  • On May 29, 2025 Nasdaq informed MetaVia it was not in compliance because the closing bid had been below $1.00 for 30 consecutive trading days.
  • MetaVia requested a 180-day compliance extension on November 7, 2025; Nasdaq granted the extension on November 26, 2025, extending the cure period to May 26, 2026 (per Nasdaq Listing Rule 5810(c)(3)(A)).
  • The company met the $1.00 minimum closing bid for 10 consecutive business days (Dec 5–Dec 18, 2025), and Nasdaq's December 19, 2025 Notice closed the matter.

Why It Matters
Regaining compliance means MetaVia avoids immediate delisting proceedings tied to the Nasdaq minimum bid-price rule and remains listed on the Nasdaq Capital Market for now. For investors, that preserves current trading access and liquidity associated with a Nasdaq listing; it also removes an immediate regulatory uncertainty that had been disclosed earlier in 2025.